ATE356217T1 - Rekombinante mikroorganismen - Google Patents

Rekombinante mikroorganismen

Info

Publication number
ATE356217T1
ATE356217T1 AT00958787T AT00958787T ATE356217T1 AT E356217 T1 ATE356217 T1 AT E356217T1 AT 00958787 T AT00958787 T AT 00958787T AT 00958787 T AT00958787 T AT 00958787T AT E356217 T1 ATE356217 T1 AT E356217T1
Authority
AT
Austria
Prior art keywords
seq
recombinant microorganisms
promoter
protein
mucosal
Prior art date
Application number
AT00958787T
Other languages
English (en)
Inventor
Richard William Titball
Helen Lisa Bullifent
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE356217(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9921275.5A external-priority patent/GB9921275D0/en
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE356217T1 publication Critical patent/ATE356217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00958787T 1999-09-10 2000-09-06 Rekombinante mikroorganismen ATE356217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921275.5A GB9921275D0 (en) 1999-09-10 1999-09-10 Recombinant microorganisms
GBGB0017000.1A GB0017000D0 (en) 1999-09-10 2000-07-12 Recombinant microorganisms

Publications (1)

Publication Number Publication Date
ATE356217T1 true ATE356217T1 (de) 2007-03-15

Family

ID=26244633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958787T ATE356217T1 (de) 1999-09-10 2000-09-06 Rekombinante mikroorganismen

Country Status (8)

Country Link
EP (1) EP1210445B1 (de)
JP (1) JP2003509046A (de)
AT (1) ATE356217T1 (de)
AU (1) AU777298B2 (de)
CA (1) CA2382067A1 (de)
DE (1) DE60033823T2 (de)
GB (1) GB2369618B (de)
WO (1) WO2001019974A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1670505B1 (de) 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna-promotor und anthrax-vakzine
GB0501540D0 (en) * 2005-01-25 2005-03-02 Univ Leeds Controlled production and delivery of biologically active agents by gut bacteria
JP5085547B2 (ja) * 2005-08-30 2012-11-28 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 生理活性ポリペプチドの細菌性送達
EP1984022A2 (de) * 2006-01-17 2008-10-29 CREATOGEN Laboratories GmbH Influenzaimpfstoff
CN112546210A (zh) * 2020-12-15 2021-03-26 南京农业大学 一种沙门菌灭活疫苗的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines
US5733760A (en) * 1994-08-05 1998-03-31 Virus Research Institute Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof
DE69625802T2 (de) * 1995-03-13 2003-11-13 The Secretary Of State For Defence, Salisbury Impfstoffe gegen die pest
DE69935927T2 (de) * 1998-12-02 2008-01-10 University Of Maryland, Baltimore Plasmidstabilisierungssystem für die verabreichung von antigenen

Also Published As

Publication number Publication date
GB0203213D0 (en) 2002-03-27
DE60033823D1 (de) 2007-04-19
EP1210445A2 (de) 2002-06-05
AU7020600A (en) 2001-04-17
WO2001019974A3 (en) 2001-11-15
EP1210445B1 (de) 2007-03-07
WO2001019974A2 (en) 2001-03-22
GB2369618A (en) 2002-06-05
CA2382067A1 (en) 2001-03-22
JP2003509046A (ja) 2003-03-11
AU777298B2 (en) 2004-10-07
GB2369618B (en) 2004-06-02
DE60033823T2 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DK0618976T3 (da) Syntetisk DNA-sekvens med forbedret insekticid virkning i majs
WO2001047952A3 (en) Insecticidal proteins from bacillus thuringiensis
DK1165791T3 (da) Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
NZ595496A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
EP2177534A3 (de) Heteroklitische Analoga von Klasse-i Epitopen
TR199501182A2 (tr) Pestisid özellikte yeni proteinler ve suslar.
CA2185712A1 (en) Enhanced virus-mediated dna transfer
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
EP1988099A3 (de) Insektizide Proteine von Bacillus thuringiensis
ATE130869T1 (de) Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.
DE60043428D1 (de) POLYPEPTIDE MIT VERZWEIGUNGSENZYM-AKTIVITäT UND FüR DIESE KODIERENDE NUKLEINSäUREN
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE60033823D1 (de) Rekombinante mikroorganismen
GB9901499D0 (en) Biological control
AU3082795A (en) Hard and soft wheat thioredoxins h, homologous proteins, dna fragments coding for said proteins and methods for preparing same
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
WO2000006713A8 (en) Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
ATE399794T1 (de) Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
DE69828902D1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties